ATC code A14
ATC code A14 is a section of the Anatomical Therapeutic Chemical Classification System (ATC), which is used for the classification of drugs and other medical substances. This specific code is designated for anabolic agents for systemic use.
Overview[edit]
ATC code A14 is part of a larger system used worldwide to facilitate the organization of medicines into different groups according to the organ or system on which they act and their therapeutic, pharmacological, and chemical properties. This system is controlled by the World Health Organization (WHO) and is used in many countries to help improve prescription, dispensation, and storage of medicines.
Classification[edit]
The ATC code A14 is subdivided into several second-level codes, each corresponding to a specific class of substances:
- A14A - Anabolic steroids
- A14B - Other anabolic agents
Each of these categories is further divided into more specific subcategories that detail individual drugs or compounds.
A14A - Anabolic Steroids[edit]
Anabolic steroids are used primarily to treat conditions involving muscle loss or poor bone density. These substances promote muscle growth and can also have other metabolic effects. Common examples include:
- A14AA - Androstan derivatives
- A14AB - Estren derivatives
- A14AC - Other anabolic steroids
A14B - Other Anabolic Agents[edit]
This category includes drugs that are not steroids but have similar anabolic effects. These are less commonly used and have specific applications in certain medical conditions.
Usage[edit]
Drugs classified under ATC code A14 are primarily used in the treatment of conditions like anemia, osteoporosis, and to help reverse catabolic states, such as those seen in long-term corticosteroid therapy or chronic infections. They are also used illicitly for muscle building by athletes and bodybuilders.
Regulation and Controversy[edit]
Due to their potential for misuse, substances under the A14 code are tightly regulated in many countries. Their use in sports is banned by most international sports organizations due to the unfair advantage they provide and their potential health risks, which can include liver damage, increased risk of heart disease, hormonal imbalances, and behavioral changes.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
